After decades, RAS mutation has finally become a therapeutic target

Per Med. 2021 Sep;18(6):523-525. doi: 10.2217/pme-2021-0015. Epub 2021 Oct 18.
No abstract available

Keywords: AMG 510; KRAS; KRAS G12C; NSCLC; RAS; adagrasib; cancer; proto-oncogene; sotorasib; targeted therapies.

Publication types

  • Editorial

MeSH terms

  • Carcinoma, Non-Small-Cell Lung*
  • Genes, ras
  • Humans
  • Lung Neoplasms*
  • Mutation / genetics